SIPC Stock Overview
Engages in the manufacture and sale of generic medicines in Egypt. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Sabaa International Company for Pharmaceutical and Chemical Industry Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م1.39 |
| 52 Week High | ج.م1.85 |
| 52 Week Low | ج.م0.61 |
| Beta | 0.50 |
| 1 Month Change | -4.14% |
| 3 Month Change | 84.11% |
| 1 Year Change | 74.84% |
| 3 Year Change | 29.91% |
| 5 Year Change | 79.09% |
| Change since IPO | 65.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| SIPC | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | -6.1% | -2.7% | -1.5% |
| 1Y | 74.8% | 31.9% | 28.7% |
Return vs Industry: SIPC exceeded the EG Pharmaceuticals industry which returned 27.9% over the past year.
Return vs Market: SIPC exceeded the EG Market which returned 27.5% over the past year.
Price Volatility
| SIPC volatility | |
|---|---|
| SIPC Average Weekly Movement | 14.9% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in EG Market | 8.8% |
| 10% least volatile stocks in EG Market | 3.3% |
Stable Share Price: SIPC's share price has been volatile over the past 3 months compared to the EG market.
Volatility Over Time: SIPC's weekly volatility has increased from 9% to 15% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 165 | Sahal Morsi Al-Damrawi | www.sabaapharmagroup.com |
Sabaa International Company for Pharmaceutical and Chemical Industry engages in the manufacture and sale of generic medicines in Egypt. It offers hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets, such as Claudol and Flamogen E.C.T. The company also provides OTCs, food supplements, and veterinary products, as well as medicine trials services.
Sabaa International Company for Pharmaceutical and Chemical Industry Fundamentals Summary
| SIPC fundamental statistics | |
|---|---|
| Market cap | ج.م347.50m |
| Earnings (TTM) | -ج.م8.61m |
| Revenue (TTM) | ج.م15.56m |
22.3x
P/S Ratio-40.4x
P/E RatioIs SIPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIPC income statement (TTM) | |
|---|---|
| Revenue | ج.م15.56m |
| Cost of Revenue | ج.م10.08m |
| Gross Profit | ج.م5.48m |
| Other Expenses | ج.م14.08m |
| Earnings | -ج.م8.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.034 |
| Gross Margin | 35.22% |
| Net Profit Margin | -55.30% |
| Debt/Equity Ratio | 31.2% |
How did SIPC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:18 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sabaa International Company for Pharmaceutical and Chemical Industry is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|